10 Mar 2020

Lung imaging software may fast-track coronavirus diagnosis

4DX chief executive and founder Andreas Fouras. Picture: Roy VanDerVegt   Posted on The Australian, 11 March 2020 An Australian medical technology company is hoping to forge the pathway to a fast-tracked coronavirus diagnosis by reducing the ­diagnostic time to three hours. 4DX is seeking to partner with an Australian hospital to conduct clinical trials […]

11 Feb 2020

4Dx article – Mirage News

  4Dx in the news!  Check out the latest article on our technology on the Mirage News website:

13 Jan 2020

4Dx Hiring

4Dx is continuing to grow! Two new job postings for the Melbourne office were posted today on our Careers page:

10 Dec 2019

4Dx $15 million Pre-IPO News Hits News Outlets

New news releases from BioMelbourne Network and Biotech Daily, Dec. 10, 2019: (   ****************** 10 December 2019 Melbourne, Australia: Australian medical technology company 4Dx Limited has raised $15 million in a heavily oversubscribed pre-IPO. The funds raised via the unsecured converting note issue will be used to drive 4Dx’s go-to-market strategy by adding to […]

15 Nov 2019

4Dx Completes FDA Submission Documentation

FOR IMMEDIATE RELEASE As of November 10, 2019, 4Dx is proud to announce that all documents required to support an FDA 510(k) application have been handed over to its agent for electronic submission. After a tremendously successful clinical validation trial, 4Dx founder and CEO, Andreas Fouras, was very happy to announce the trial’s results, which […]

12 Nov 2019

Dr. Sam Hupert, CEO of Pro Medicus, Joins 4Dx Advisory Board

4Dx is pleased to announce the appointment of Dr. Sam Hupert, co-Founder and CEO of Pro Medicus (ASX: PME) to the 4Dx advisory board. Dr. Hupert has made a private investment into 4Dx and agreed to sit on 4Dx’s advisory board, bringing with him more than 37 years of success as a leader in the global […]